Vaccine News and Research

Latest Vaccine News and Research

World's largest public-private partnership focuses on tackling antibiotic resistance

The U.S. Department of Health and Human Services, the Wellcome Trust of London, the AMR Centre of Alderley Park, Cheshire in the United Kingdom and Boston University School of Law today announced the establishment of one of the world's largest public-private partnerships focused on tackling antibiotic resistance, an emerging modern threat to public health worldwide.

29 Jul 2016

MIT researchers develop portable device to manufacture biopharmaceuticals on demand

For medics on the battlefield and doctors in remote or developing parts of the world, getting rapid access to the drugs needed to treat patients can be challenging.

29 Jul 2016

T-cell technology could be used to treat ovarian tumors with no adverse effects

With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies that direct T-cells to selectively eliminate ovarian tumor cells, but an appropriate therapeutic target for ovarian cancers has remained elusive.

29 Jul 2016

NIAID begins early-stage trial of experimental vaccine for preventing yellow fever virus

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has begun an early-stage clinical trial of an investigational vaccine designed to protect against yellow fever virus.

27 Jul 2016

New screen-and-treat programme for hepatitis B may thwart deadly complications of disease

Research into Africa's first 'screen-and-treat' programme for hepatitis B suggests the initiative may reduce deadly complications of the virus.

27 Jul 2016

Scientists develop prediction score to identify older adults at risk of developing pneumonia

In a study published in the Journal of American Geriatrics Society, researchers developed a "prediction score" to help healthcare professionals determine which older adults might be most at risk for developing pneumonia.

26 Jul 2016

Scientists unveil structure of Zika NS1 protein

Researchers have revealed the molecular structure of a protein produced by the Zika virus that is thought to be involved in the virus's reproduction and its interaction with a host's immune system.

26 Jul 2016

Scientists discover vaccine-induced antibodies that can counteract varied strains of influenza virus

Scientists have identified three types of vaccine-induced antibodies that can neutralize diverse strains of influenza virus that infect humans.

22 Jul 2016

Penn researchers construct model to examine how immune system may evolve to conquer HIV

It has remained frustratingly difficult to develop a vaccine for HIV/AIDS, in part because the virus, once in our bodies, rapidly reproduces and evolves to escape being killed by the immune system.

22 Jul 2016

Scientists design and construct 10 large protein icosahedra to improve drug delivery

Using novel computational and biochemical approaches, scientists have accurately designed and built from scratch 10 large protein icosahedra--polyhedra with 20 faces--similar to viral capsids that carry viral DNA.

22 Jul 2016

Texas Biomed scientists receive $23 million NIH grant to develop AIDS vaccine

To support a coordinated, innovative approach to the development of an AIDS vaccine, Texas Biomedical Research Institute scientists, together with a multi-institutional coalition of experts from the United States and Europe, have received a grant for $23 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

22 Jul 2016

WHO urges countries to take rapid action to reduce new infections, deaths from viral hepatitis

Ahead of World Hepatitis Day, 28 July 2016, WHO is urging countries to take rapid action to improve knowledge about the disease, and to increase access to testing and treatment services.

21 Jul 2016

Penn researchers develop plant-based oral vaccine booster

Jonas Salk created a vaccine against polio that has been used since 1955; Albert Sabin created another version that has been on the market since 1961. Together, these two vaccines have nearly eliminated polio from the face of the earth.

20 Jul 2016

JAIDS presents important information to prevent HIV epidemic among transgender individuals

Programs to reduce the high risk of HIV infection among transgender people are urgently needed—but efforts are hindered by a lack of accurate information on HIV prevalence, HIV incidence, and specific risk factors facing this key population.

20 Jul 2016

Increasing rates of new HIV infections threaten 74 countries

AIDS deaths are falling in most countries worldwide, but the rate of new infections increased in several countries over the past decade, threatening to undermine efforts to end the AIDS epidemic by 2030, a new scientific paper shows.

20 Jul 2016

First clinical study for Zika vaccine to begin in Canada

Université Laval's Infectious Disease Research Centre and Centre de recherche du CHU de Québec-Université Laval are proud to announce that the first clinical study for a Zika vaccine in Canada is set to begin in Quebec City.

19 Jul 2016

Researchers develop first protective vaccine against insidious STI

The first steps towards developing a vaccine against an insidious sexual transmitted infection (STI) have been accomplished by researchers at McMaster University.

19 Jul 2016

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

A biopharmaceutical company collaborating with Hawai'i scientists on an Ebola vaccine announced encouraging news about its vaccine today.

19 Jul 2016

Novel device for mitral valve repair shows success in human study

Researchers investigating a novel device to repair the mitral heart valve report 100 percent procedural success in a safety and performance study, the first such study done in humans.

19 Jul 2016

SLU researchers study investigational vaccine for yellow fever

Saint Louis University's Center for Vaccine Development is studying an investigational vaccine for yellow fever, a potentially deadly disease that is spread by the same mosquito that transmits Zika virus.

19 Jul 2016

Vaccine News and Research

Latest Vaccine News and Research

World's largest public-private partnership focuses on tackling antibiotic resistance

MIT researchers develop portable device to manufacture biopharmaceuticals on demand

T-cell technology could be used to treat ovarian tumors with no adverse effects

NIAID begins early-stage trial of experimental vaccine for preventing yellow fever virus

New screen-and-treat programme for hepatitis B may thwart deadly complications of disease

Scientists develop prediction score to identify older adults at risk of developing pneumonia

Scientists unveil structure of Zika NS1 protein

Scientists discover vaccine-induced antibodies that can counteract varied strains of influenza virus

Penn researchers construct model to examine how immune system may evolve to conquer HIV

Scientists design and construct 10 large protein icosahedra to improve drug delivery

Texas Biomed scientists receive $23 million NIH grant to develop AIDS vaccine

WHO urges countries to take rapid action to reduce new infections, deaths from viral hepatitis

Penn researchers develop plant-based oral vaccine booster

JAIDS presents important information to prevent HIV epidemic among transgender individuals

Increasing rates of new HIV infections threaten 74 countries

First clinical study for Zika vaccine to begin in Canada

Researchers develop first protective vaccine against insidious STI

Soligenix announces encouraging preliminary results of heat stable Ebola vaccine

Novel device for mitral valve repair shows success in human study

SLU researchers study investigational vaccine for yellow fever

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in